Key result
Residual symptoms and slow gait at discharge linked to ~177% higher 2-year mortality.
Why the study?
Older patients may underreport subjective heart failure symptoms due to age-related physical decline, leaving the prognostic significance of residual symptoms across physical performance levels unclear.
Does the presence of residual symptoms and low physical performance at discharge predict all-cause death in older patients hospitalized for worsening heart failure?
Cohort (n=1,272)
Does the presence of residual symptoms and low physical performance at discharge predict all-cause death in older patients hospitalized for worsening heart failure?
Residual symptoms and low physical performance at discharge are independently associated with higher 2-year all-cause mortality in older patients hospitalized for worsening heart failure.
Answers are grounded in this paper and cite their sources.
Residual symptoms at discharge may flag higher-risk older HF patients; leaves open whether targeted interventions improve survival.
BACKGROUND: The New York Heart Association (NYHA) classification is well-established prognostic indicator and treatment goal in heart failure (HF). However, older patients may underreport subjective symptoms due to age-related physical decline. The prognostic significance of residual symptoms in older patients hospitalized for worsening HF, particularly across physical performance levels, remains unclear. We aimed to evaluate the significance of residual symptoms and physical performance at discharge on outcomes. METHODS: This FRAGILE-HF sub-analysis included 1272 consecutive hospitalized patients with HF aged ≥ 65 years (mean age 80.1 ± 7.8 years; 57.2% men; left ventricular ejection fraction 46 ± 17%). Pre-discharge NYHA class and 4-meter gait speed assessed residual symptoms and physical performance. Patients were followed up for 2 years post-discharge, with all-cause death within 2 years as the primary outcome. RESULTS: At discharge, 715 patients (56.2%) remained symptomatic (NYHA class 2-4) while 557 patients (43.8%) were asymptomatic (NYHA class 1). Patients were stratified into four groups based on residual symptoms and physical performance (slow gait speed: < 0.8 m/s; normal speed ≥ 0.8 m/s). During follow-up, 266 patients (20.9%) died. Compared with normal-asymptomatic patients, adjusted hazard ratios for all-cause death were 1.96, 1.81, and 2.77 for normal-symptomatic, slow-asymptomatic, and slow-symptomatic patients, respectively. Residual symptoms at discharge were associated with increased mortality, irrespective of gait speed (p-values for interaction: 0.393). CONCLUSION: Residual symptoms at discharge were associated with higher all-cause death, regardless of physical performance. However, patients with low physical performance may require closer follow-up, even if symptoms are alleviated at discharge.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2026) conducted a cohort in worsening heart failure (n=1,272). Residual symptoms and slow gait speed vs. Asymptomatic and normal gait speed was evaluated on all-cause death within 2 years (HR 1.96, 1.81, and 2.77). Residual symptoms at discharge were associated with higher 2-year all-cause mortality, with the highest risk observed in slow-symptomatic patients compared to normal-asymptomatic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: